ENTITY
Novo Nordisk

Novo Nordisk (NOVOB DC)

87
Analysis
Health Care • Denmark
Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.
more
bullish•Novo Nordisk
•12 Jun 2026 18:10

Primer: Novo Nordisk (NOVOB DC) - Jun 2026

Novo Nordisk is a global leader in diabetes and obesity care, capitalizing on the immense success of its GLP-1 franchise, including Ozempic and...

Logo
104 Views
Share
x